Nestle to refocus on core business, CEO says
Nestle
is refocusing on the group's
core business
after straying into segments like
health supplements
that "weakened the fabric of the organisation,"
CEO Laurent Freixe
was quoted as saying in the Financial Times on Thursday.
Freixe, who took the helm of the company in September, told the newspaper he did not see the merits of slimming down the company's portfolio, except in segments where Nestle was not in a position to win.
"I think we should never forget that M&A is not the strategy," he was quoted as saying.
In another interview earlier this week, Freixe said Nestle was recovering market share in the U.S. despite concerns stemming from the Trump administration's imposition of tariffs on its key trading partners last month.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
Jane Street to contest SEBI's manipulation charges: Reports
Jane Street rejects allegations Jane Street vs SEBI Live Events Pushback on exchange claims (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Securities and Exchange Board ( SEBI ) has accused Jane Street , one of Wall Street's biggest trading firms, of running what it calls 'an intentional, well planned, and sinister scheme' to distort the country's markets. The Financial Times reported the regulator's findings on Monday. Reuters has not verified this Friday, SEBI barred Jane Street from trading in India and ordered it to return over 550 million dollars of what it describes as illegal profit. The ban follows allegations that Jane Street moved Indian bank stocks in ways that triggered large payouts on connected Street has told staff it will fight the ban. In a memo sent on Sunday to around 3,000 employees, senior management wrote they were 'beyond disappointed' by SEBI's 'extremely inflammatory' accusations.'It's deeply upsetting to see the firm mischaracterised this way,' said the memo, quoted by the Financial Times. 'We take pride in the role we serve in markets around the world, and it's painful to have our firm's reputation tarnished by a report based on so many erroneous or unsupported assertions.'Jane Street's trouble with SEBI links back to a lawsuit it filed last year against Millennium Management and two former traders who left for the hedge fund. In that case, Jane Street claimed the traders stole a valuable strategy that turned out to centre on Indian options. SEBI's probe zoomed in on Jane Street's trades linked to the BANKNIFTY index, which tracks India's major banking are now checking other parts of India's markets too. Jane Street has argued that the trades flagged by SEBI were nothing more than 'basic arbitrage trading', a normal practice in the order also says Jane Street ignored warnings from local stock exchanges. The firm disputes this point strongly. In the same memo to staff, Jane Street said the regulator used 'a metric for market impact and trading aggressiveness which seems disconnected from actual market dynamics'.The memo added that when exchanges first raised concerns, the firm 'immediately turned off its trading until we could better understand the exchanges' concerns' and later changed its approach to meet their 'preferences'.'Once again, we left this process feeling that we had reached an understanding of the concerns and reflected them in modifications to our trading behaviour,' the memo said. 'Since February, we have made ongoing efforts to communicate with SEBI and have been consistently rebuffed.'Jane Street has 21 days to object to SEBI's order and ask for a hearing. The firm says it is working on a detailed response and plans to fight the ban in the meantime, India's regulators say they may widen the investigation into other trades and instruments connected to the firm. Jane Street's future in one of Asia's biggest markets now hangs on how this fight plays out.
&w=3840&q=100)
Business Standard
11 hours ago
- Business Standard
HC grants relief to Galderma against infringers using 'CETAPHIL' trademark
The Bombay High Court has granted relief to Swiss pharmaceutical major Galderma Holdings in an intellectual property (IP) enforcement action against counterfeit products bearing its 'CETAPHIL' trademark. Galderma, acting through its Indian subsidiary Galderma India, had approached the Court seeking urgent measures to address large-scale counterfeiting of its products across online platforms and local markets. On 18 June, the Court issued a John Doe injunction order, permitting the company to take immediate action against unidentified infringers. Following the order, search and seizure operations were carried out by a team from Khaitan and Co. on 2 July in collaboration with the police and Court Receivers. The enforcement team conducted searches at manufacturing and trading locations in New Delhi and Mumbai.
India.com
14 hours ago
- India.com
7 Epic Burger Recipes You Haven't Tried Yet
Muskan Kalra Jul 04, 2025 A juicy chicken patty slathered in rich, creamy butter chicken sauce, topped with fresh coriander and onions, served on a toasted naan bun. Tender beef marinated in bulgogi sauce, grilled to perfection, stacked with spicy kimchi, gochujang mayo, and sesame slaw. A beef patty oozing with cheesy macaroni inside, topped with crispy onions and BBQ sauce for an indulgent bite. Chunks of smoky paneer tikka loaded into a burger bun with mint chutney, pickled onions, and crunchy lettuce. A gourmet vegetarian option featuring sautéed mushrooms, Swiss cheese, truffle mayo, and arugula on a brioche bun. Crispy chicken fillet topped with cream cheese, jalapeños, and pepper jack cheese, delivering a spicy, creamy punch. A protein-packed vegan burger with black beans, quinoa, corn, and southwest spices, topped with avocado and chipotle aioli. Read Next Story
